Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial : full-length article - Voci, Davide; Götschi, Andrea; Held, Ulrike; Bingisser, Roland; Colucci, Giuseppe; Dürschmied, Daniel; Fumagalli, Riccardo M.; Gerber, Bernhard; Hasse, Barbara; Keller, Dagmar I.; Konstantinides, Stavros V.; Mach, François; et al. (Thrombosis research, 2023)
Online verfügbar: 12. November 2022, Artikelversion: 22. Dezember 2022